During Thursday’s current trade, Synaptics, Incorporated (NASDAQ:SYNA)’s shares declined -0.69% to $90.36.
Synaptics Inc. (SYNA), the leading developer of human interface solutions, declared that Sharp has selected its industry-leading Natural ID™ fingerprint sensor to provide secure authentication for its latest flagship smartphone device, the AQUOS ZETA SH-03G. Having recently reached more than 200 million shipments of its fingerprint ID sensor technology, this latest shipment with Sharp reinforces Synaptics’ strength, scalability and leadership in the biometrics market through its innovative authentication solutions for global OEM partners.
Selected as part of NTT DOCOMO, INC’s newest lineup of smartphone devices for the Japanese market, the Sharp AQUOS ZETA SH-03G complies with FIDO’s latest industry standard, UAF 1.0, delivered through Synaptics’ Natural ID sensor, which utilizes unique technology to enable fingerprint authentication that can be done locally for increased data security.
Synaptics Incorporated develops, markets, and sells custom-designed human interface solutions for electronic devices and products primarily in China, South Korea, Taiwan, the United States, Japan, and other countries. The company offers its human interface solutions for mobile product applications, counting smartphones, tablets, and touchscreen applications, in addition to mobile, handheld, wireless, and entertainment devices; and other personal computer (PC) product applications, such as peripherals comprising keyboards, mice, and monitors, in addition to remote control devices for desktops, PCs, and digital home applications.
Barnes & Noble, Inc. (NYSE:BKS)‘s shares drop -2.43% to $25.69, during the current trading session Thursday’s, hitting its highest level.
Barnes & Noble, Inc. (BKS) recently stated sales and earnings for its fiscal 2015 fourth quarter and full-year ended May 2, 2015.
The fourth quarter and full-year ended May 2, 2015, compriseed of 13 weeks and 52 weeks, respectively, as contrast to 14 weeks and 53 weeks in the prior year. Comparable sales data in this release exclude the impact of the additional week in fiscal 2014 and are on a comparable week basis.
Fourth quarter merged revenues reduced 10.4% to $1.2 billion as compared to the prior year. Merged fourth quarter earnings before interest, taxes, depreciation and amortization (EBITDA) improved to $33 million, as contrast to $11 million in the prior year. For fiscal 2015, merged revenues reduced 4.9% to $6.1 billion as compared to the prior year. Fiscal 2015 merged EBITDA raised 30.4% to $327 million, as contrast to $251 million a year ago.
Barnes & Noble, Inc. operates as a content, commerce, and technology company in the United States. The company operates in three segments: B&N Retail, B&N College, and NOOK. It provides access to books, magazines, newspapers, and other content through its multi-channel distribution platform. The company sells trade books, counting hardcover and paperback consumer titles; mass market paperbacks, such as mystery, romance, science fiction, and other fiction; childrens books; eBooks and other digital content; NOOK products comprising NOOK 1st Edition, NOOK Wi-Fi 1st Edition, NOOK Color, NOOK Simple Touch, NOOK Tablet, NOOK Simple Touch with GlowLight, NOOK HD, NOOK HD+, NOOK GlowLight eReader devices, and related accessories; bargain books; magazines; gifts; cafe products and services; educational toys and games; music; and movies. It also sells textbooks and course-related materials, emblematic apparel and gifts, school and dorm supplies, and convenience and café items in college and university campuses.
In an afternoon trade, Endo International plc - Ordinary Shares (NASDAQ:ENDP)‘s shares surge 0.19% to $82.42.
Endo International plc (ENDP) (ENL.TO) (“Endo”) recently declared that (1) its wholly-owned auxiliaries, Endo Finance LLC and Endo Finco Inc., will, subject to the satisfaction of the condition described below, redeem all $481,894,000 aggregate principal amount outstanding of their 7.00% Senior Notes due 2019 (CUSIP Nos. 29271L AB0, U2918V AB1) (the “2019 Endo Finance Notes”) on July 24, 2015 and (2) its wholly-owned partner, Endo Health Solutions Inc. (“EHSI”), will, subject to the satisfaction of the condition described below, redeem all $17,981,000 aggregate principal amount outstanding of its 7.00% Senior Notes due 2019 (CUSIP No. 29264F AG1) (the “2019 EHSI Notes” and, together with the 2019 Endo Finance Notes, the “Notes”) on July 24, 2015. Each of the redemptions is conditional and subject to the delivery of moneys sufficient to pay the applicable redemption price to Wells Fargo Bank, National Association, 150 East 42nd Street, 40th Floor, New York, New York 10017, as trustee under the indentures governing the Notes (the “Trustee”) on the redemption date.
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, counting Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology. The U.S. Generic Pharmaceuticals segment offers products in the pain administration, urology, CNS disorders, immunosuppression, oncology, women’s health, hypertension, generic lidocaine patch, and other markets.
Banro Corporation (USA) (NYSEMKT:BAA), during its Thursday’s current trading session 3.93% gain and closed at $0.331.
Banro Corporation (USA) (BAA) hereby notifies holders of Series A Preference Shares of Banro (“Banro Series A Shares”) and holders of Preferred Shares of Banro Group (Barbados) Limited (“Barbados Preferred Shares”) that further to the Company’s press release of June 16, 2015, the board of directors of each of Banro and Banro Group (Barbados) Limited has authorized and declared a dividend payable of US$0.75 per Banro Series A Share and Barbados Preferred Share.
The dividend is payable to holders of record of Banro Series A Shares and Barbados Preferred Shares on June 26, 2015 and will be paid on June 30, 2015.
Banro Corporation, together with its auxiliaries, engages in the exploration, development, and production of mineral properties. It primarily explores for gold. The company holds a 100% interest in 4 gold properties, counting Twangiza, Namoya, Lugushwa, and Kamituga comprising 13 exploitation permits that cover an area of about 2,612 square kilometers in the South Kivu and Maniema provinces of the Democratic Republic of the Congo. It also owns 14 exploration permits covering an area of about 2,638 square kilometers located between the Twangiza and Namoya properties.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
